Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, Mantle-Cell × R-CHOP protocol × Clear all

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Non-Hodgkin 2 Recurrence 1 Lymphoma, Mantle-Cell 1

Interventions

Rituximab 21 Cyclophosphamide 11 Bendamustine Hydrochloride 8 ibrutinib 7 Vincristine 7 Radiotherapy 7 Prednisone 7 Doxorubicin 7 Filgrastim 5 zanubrutinib 4 Peripheral Blood Stem Cell Transplantation 4 Interferon-alpha 3 Cyclosporine 3 venetoclax 2 orelabrutinib 2 fludarabine 2 acalabrutinib 2 Psychiatric Rehabilitation 2 Mycophenolic Acid 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Levofloxacin 2 Lenalidomide 2 Etoposide 2 Epoetin Alfa 2 Dexamethasone 2 Darbepoetin alfa 2 Cytarabine 2 Cyclosporins 2 Busulfan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00209209 2017-03-07

MCLelderly

European Mantle Cell Lymphoma Network

Phase 3 Unknown

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡